Author:
Publisher: Am Cncl on Science, Health
ISBN:
Category :
Languages : en
Pages : 35
Book Description
Counterfeit Drugs: Coming to a Pharmacy Near You (2009)
Author:
Publisher: Am Cncl on Science, Health
ISBN:
Category :
Languages : en
Pages : 35
Book Description
Publisher: Am Cncl on Science, Health
ISBN:
Category :
Languages : en
Pages : 35
Book Description
Countering the Problem of Falsified and Substandard Drugs
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377
Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377
Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.
Drug Safety in Developing Countries
Author: Yaser Mohammed Al-Worafi
Publisher: Academic Press
ISBN: 0128204125
Category : Medical
Languages : en
Pages : 656
Book Description
Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. - Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues - Describes current achievements of drug safety practice in developing countries - Addresses the challenges of drug safety in developing countries - Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety
Publisher: Academic Press
ISBN: 0128204125
Category : Medical
Languages : en
Pages : 656
Book Description
Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. - Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues - Describes current achievements of drug safety practice in developing countries - Addresses the challenges of drug safety in developing countries - Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Pharmacy Management, Leadership, Marketing, and Finance
Author: Marie A. Chisholm-Burns
Publisher: Jones & Bartlett Publishers
ISBN: 1449657257
Category : Drugstores
Languages : en
Pages : 617
Book Description
Publisher: Jones & Bartlett Publishers
ISBN: 1449657257
Category : Drugstores
Languages : en
Pages : 617
Book Description
Crime and Terrorism Risk
Author: Leslie W. Kennedy
Publisher: Taylor & Francis
ISBN: 1135851921
Category : Business & Economics
Languages : en
Pages : 305
Book Description
Crime and Terrorism Risk is a collection of original essays and articles that presents a broad overview of the issues related to the assessment and management of risk in the new security age. These original articles show how researchers, experts and the public are beginning to think about crime and terrorism issues in terms of a new risk paradigm that emphasizes establishing a balance between threat and resources in developing prevention and response strategies.
Publisher: Taylor & Francis
ISBN: 1135851921
Category : Business & Economics
Languages : en
Pages : 305
Book Description
Crime and Terrorism Risk is a collection of original essays and articles that presents a broad overview of the issues related to the assessment and management of risk in the new security age. These original articles show how researchers, experts and the public are beginning to think about crime and terrorism issues in terms of a new risk paradigm that emphasizes establishing a balance between threat and resources in developing prevention and response strategies.
Counterfeit Medicines: Policy, economics, and countermeasures
Author: Albert I. Wertheimer
Publisher: ILM Publications
ISBN: 1906799083
Category : Business & Economics
Languages : en
Pages : 156
Book Description
"Discusses the economic and financial consequences of pharmaceutical product counterfeiting and describes some of the measures that can be taken to counteract their impact"--Provided by publisher.
Publisher: ILM Publications
ISBN: 1906799083
Category : Business & Economics
Languages : en
Pages : 156
Book Description
"Discusses the economic and financial consequences of pharmaceutical product counterfeiting and describes some of the measures that can be taken to counteract their impact"--Provided by publisher.
The Illegal Trade of Medicines on Social Media
Author: Gabriele Baratto
Publisher: Springer Nature
ISBN: 3030575829
Category : Social Science
Languages : en
Pages : 122
Book Description
This book evaluates the impact of situational crime prevention measures implemented by social media platforms to identifying, blocking, and removing content linked to illegal traded medicines. It discusses the extent of social media usage in trafficking of medicines; the ease of access; visibility of the content; language of posts; products most traded; and types of posts. Research results support the hypothesis of the limited impact of these measures, due not to a lack of effectiveness but to asymmetrical implementation. This volume will be of interest to researchers, law enforcement, policy makers, social media groups, public health practitioners.
Publisher: Springer Nature
ISBN: 3030575829
Category : Social Science
Languages : en
Pages : 122
Book Description
This book evaluates the impact of situational crime prevention measures implemented by social media platforms to identifying, blocking, and removing content linked to illegal traded medicines. It discusses the extent of social media usage in trafficking of medicines; the ease of access; visibility of the content; language of posts; products most traded; and types of posts. Research results support the hypothesis of the limited impact of these measures, due not to a lack of effectiveness but to asymmetrical implementation. This volume will be of interest to researchers, law enforcement, policy makers, social media groups, public health practitioners.
OECD Reviews of Risk Management Policies Illicit Trade Converging Criminal Networks
Author: OECD
Publisher: OECD Publishing
ISBN: 9264251847
Category :
Languages : en
Pages : 266
Book Description
This report assesses the magnitude, flows and drivers of illicit trade and the illegal economy including: narcotics, human trafficking, wildlife, sports betting, counterfeit medicines, alcohol and tobacco.
Publisher: OECD Publishing
ISBN: 9264251847
Category :
Languages : en
Pages : 266
Book Description
This report assesses the magnitude, flows and drivers of illicit trade and the illegal economy including: narcotics, human trafficking, wildlife, sports betting, counterfeit medicines, alcohol and tobacco.
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries
Author: Mohamed Izham Mohamed Ibrahim
Publisher: Academic Press
ISBN: 0128112298
Category : Medical
Languages : en
Pages : 486
Book Description
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries. While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face. - Examines key issues and challenges of pharmacy practice and the pharmaceutical sector specific to low- and middle-income countries - Compares pharmacy practice in developed and developing countries to highlight the unique challenges and opportunities of each - Provides a blueprint for the future of pharmacy in low- and middle-income countries, including patient-centered care, evidence-based care and promoting the role of the pharmacist for primary health care in these settings
Publisher: Academic Press
ISBN: 0128112298
Category : Medical
Languages : en
Pages : 486
Book Description
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries. While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face. - Examines key issues and challenges of pharmacy practice and the pharmaceutical sector specific to low- and middle-income countries - Compares pharmacy practice in developed and developing countries to highlight the unique challenges and opportunities of each - Provides a blueprint for the future of pharmacy in low- and middle-income countries, including patient-centered care, evidence-based care and promoting the role of the pharmacist for primary health care in these settings